FDA Moves to Resume Use of J&J COVID Vaccine
Johnson & Johnson has agreed with the U.S. Food and Drug Administration to add a warning label to the vaccine
Pfizer and Moderna Vaccines Effective Against New NYC Variant
Studies add to growing evidence that the two vaccines protect against all coronavirus variants identified so far
FDA Approves Immunotherapy for dMMR Endometrial Cancer
Jemperli approved for dMMR endometrial cancer that progressed after platinum-containing chemotherapy treatment
Few SARS-CoV-2 Vaccine Breakthrough Infections Reported at SNFs
22 infections identified among 12 residents and 10 staff members at 15 skilled nursing facilities; no facility-associated secondary transmission reported
Once-Weekly Insulin Icodec Promising for Type 2 Diabetes
Icodec results in greater increase in time-in-range versus once-daily insulin glargine U100 in two phase 2 randomized, open-label trials
Guidance Updated for Assessing Allergy Risk of COVID-19 Vaccines
Janssen adenovirus type 26 vectored vaccine may be considered for individuals who self-report PEG allergy
Sacituzumab Govitecan Treats Metastatic Triple-Negative Breast Cancer
Progression-free, overall survival prolonged with sacitizumab govitecan versus single-agent chemotherapy
Survivors of Adolescent, Young Adult Cancer Face Financial Hardships
Hardships include forgoing care and medication nonadherence due to cost
No Obvious Safety Signals ID’d for mRNA COVID-19 Vaccine in Pregnancy
Adverse neonatal outcomes included preterm birth and small for gestational age; no neonatal deaths reported
One COVID-19 Vaccine Dose Wasted for Every 850 Used: CDC Data
Data also show that pharmacies accounted for three-quarters of the reported wastage
